Research examining patients with type 2 diabetes found that those taking tirzepatide were 65% less likely to be diagnosed with depression and 60% less likely to be diagnosed with anxiety compared to patients not taking the medication
Xueli Z, Yi Z, Shuobing C, Hua S
For example, some patients may gradually improve as lifestyle changes begin to take effect over time
At the beginning of the year, Becton, Dickinson announced it would invest $110 million to expand its production capacity for prefillable syringes to support the rising demand for GLP-1 drugs
What we promise is transparency and honesty: you will know your options and your price before anything is done, and we will tell you plainly if a different treatment is a better use of your money
Vinjamoori and Egler do have a point